CircRFX3 contributes to glioma progression through the circRFX3-miR-1179/miR-1229-VASP axis

Table 1 Correlation between circRFX3 expression and the clinical pathological features of 50 glioma patients

Characteristic	All cases (n = 50)	circRFX3 expression		P-value
Characteristic	All cases (n = 50)	High(n = 25)	Low(n = 25)	P-value
Age (years)				0.563
< 50	20	11	9
≥ 50	30	14	16
Sex				0.774
Male	29	14	15
Female	21	11	10
Tumor size, cm				0.395
> 4.5	23	13	10
≤ 4.5	27	12	15
MGMT				0.001*
Unmeth	25	7	18
Meth	25	18	7
WHO grade				0.024*
I–II	24	8	16
III–IV	26	17	9
IDH mutation status				0.145
IDH-mutated	20	13	7
IDH-wildtype	30	12	18

ISSN: 1475-2867